NIH head mulls royalties for drugmakers; PACS systems for cardiology?;

> Think the pharmas will like this proposal? The new head of NIH is considering plans to charge royalty fees to pharmas whose drug discoveries piggyback off of federally-supported research. FiercePharma

> Picture archiving and communications systems (PACS) are very popular, but most are used primarily in radiology. Now, advocates are suggesting that cardiology is another area ripe for PACS use. FierceHealthIT

> Workhorse diabetes drug metformin is proving to be a powerful weapon in the fight against cancer when combined with doxorubicin, a standard chemotherapy drug. FierceBiotechResearch

> Are you one of the skeptics worried that the current push to install EMRs can't possibly solve all of the industry's problems? You're not alone: Check out this week's Journal of the American Medical Association, which includes two articles taking that position. FierceEMR

And Finally... A once-mighty financial institution auctions off its multi-million-dollar art collection. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.